Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept
NCT02125864
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Exudative Age-related Macular Degeneration
Interventions
PROCEDURE:
intravitreal injection
Sponsor
Oslo University Hospital